SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the VeriDose™ CYP2D6 CNV panel designed to provide PGx ...
Pharmacogenomics – testing a patient’s genetic makeup to guide safer, more effective medication choices and dosing – is not a new concept. But, like so many other clinical innovations, adoption has ...
New PGx Panel with Comprehensive Genetic and Non-Genetic Coverage Promise Improved Patient Outcomes and Tailored Healthcare Solutions SAN ANTONIO, TX, UNITED STATES, May 1, 2023/einpresswire.com / -- ...
“Sequenom customers have been successful in developing assays for a wide variety of ADME biomarkers, and numerous high-impact studies have been published using Sequenom technology,” said Michael Monko ...
STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that Applied DNA ...
Pharmacogenetic (PGx) testing involves the analysis of genes known to affect response to medications. The field has been projected as a leading application of personalized or precision medicine, but ...
Invitae, a leading medical genetics company, announced the commercial availability of the expanded Invitae Pharmacogenomics (PGx) Panel which includes the specialized Invitae Pharmacogenomics Mental ...
FREMONT, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Paragon Genomics, Inc., a global leader in target enrichment solutions for next-generation sequencing (NGS), today announced the launch of its new ...
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind ®, a leading mental health care company, is launching on August 10, 2019 Genomind Professional PGx Express™, a new, more focused report and set of ...
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind®, the leading mental health company bringing precision medicine into mainstream mental health treatment, today announced the assignment of a Z-code for ...
KALAMAZOO, MA, UNITED STATES, December 6, 2022 / EINPresswire.com / -- Genemarkers, a leader in genomic research and pharmacogenomics, announced today that the New York State Department of Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results